These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 35155224)

  • 1. PFKFB3 Regulates Chemoresistance, Metastasis and Stemness
    Jiang YX; Siu MKY; Wang JJ; Leung THY; Chan DW; Cheung ANY; Ngan HYS; Chan KKL
    Front Oncol; 2022; 12():748403. PubMed ID: 35155224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascites-derived ALDH+CD44+ tumour cell subsets endow stemness, metastasis and metabolic switch via PDK4-mediated STAT3/AKT/NF-κB/IL-8 signalling in ovarian cancer.
    Jiang YX; Siu MK; Wang JJ; Mo XT; Leung TH; Chan DW; Cheung AN; Ngan HY; Chan KK
    Br J Cancer; 2020 Jul; 123(2):275-287. PubMed ID: 32390009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PFKFB3 regulates cancer stemness through the hippo pathway in small cell lung carcinoma.
    Thirusangu P; Ray U; Sarkar Bhattacharya S; Oien DB; Jin L; Staub J; Kannan N; Molina JR; Shridhar V
    Oncogene; 2022 Aug; 41(33):4003-4017. PubMed ID: 35804016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers.
    Mondal S; Roy D; Sarkar Bhattacharya S; Jin L; Jung D; Zhang S; Kalogera E; Staub J; Wang Y; Xuyang W; Khurana A; Chien J; Telang S; Chesney J; Tapolsky G; Petras D; Shridhar V
    Int J Cancer; 2019 Jan; 144(1):178-189. PubMed ID: 30226266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β1 targets Smad, p38 MAPK, and PI3K/Akt signaling pathways to induce PFKFB3 gene expression and glycolysis in glioblastoma cells.
    Rodríguez-García A; Samsó P; Fontova P; Simon-Molas H; Manzano A; Castaño E; Rosa JL; Martinez-Outshoorn U; Ventura F; Navarro-Sabaté À; Bartrons R
    FEBS J; 2017 Oct; 284(20):3437-3454. PubMed ID: 28834297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting of PFKFB3 with miR-206 but not mir-26b inhibits ovarian cancer cell proliferation and migration involving FAK downregulation.
    Boscaro C; Baggio C; Carotti M; Sandonà D; Trevisi L; Cignarella A; Bolego C
    FASEB J; 2022 Mar; 36(3):e22140. PubMed ID: 35107852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of PFKFB3 induces cell death and synergistically enhances chemosensitivity in endometrial cancer.
    Xiao Y; Jin L; Deng C; Guan Y; Kalogera E; Ray U; Thirusangu P; Staub J; Sarkar Bhattacharya S; Xu H; Fang X; Shridhar V
    Oncogene; 2021 Feb; 40(8):1409-1424. PubMed ID: 33420377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hexokinase 2 Regulates Ovarian Cancer Cell Migration, Invasion and Stemness via FAK/ERK1/2/MMP9/NANOG/SOX9 Signaling Cascades.
    Siu MKY; Jiang YX; Wang JJ; Leung THY; Han CY; Tsang BK; Cheung ANY; Ngan HYS; Chan KKL
    Cancers (Basel); 2019 Jun; 11(6):. PubMed ID: 31212816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux.
    Jones BC; Pohlmann PR; Clarke R; Sengupta S
    Cancer Metastasis Rev; 2022 Jun; 41(2):447-458. PubMed ID: 35419769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PFKFB3 works on the FAK-STAT3-SOX2 axis to regulate the stemness in MPM.
    Sarkar Bhattacharya S; Thirusangu P; Jin L; Staub J; Shridhar V; Molina JR
    Br J Cancer; 2022 Oct; 127(7):1352-1364. PubMed ID: 35794237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer.
    Yi M; Ban Y; Tan Y; Xiong W; Li G; Xiang B
    Mol Metab; 2019 Feb; 20():1-13. PubMed ID: 30553771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth.
    Clem B; Telang S; Clem A; Yalcin A; Meier J; Simmons A; Rasku MA; Arumugam S; Dean WL; Eaton J; Lane A; Trent JO; Chesney J
    Mol Cancer Ther; 2008 Jan; 7(1):110-20. PubMed ID: 18202014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of PFKFB3 in maintaining colorectal cancer cell proliferation and stemness.
    Yan S; Li Q; Li S; Ai Z; Yuan D
    Mol Biol Rep; 2022 Oct; 49(10):9877-9891. PubMed ID: 35553342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3).
    Emini Veseli B; Perrotta P; Van Wielendaele P; Lambeir AM; Abdali A; Bellosta S; Monaco G; Bultynck G; Martinet W; De Meyer GRY
    FEBS Lett; 2020 Sep; 594(18):3067-3075. PubMed ID: 32620030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
    O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
    Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) induces autophagy as a survival mechanism.
    Klarer AC; O'Neal J; Imbert-Fernandez Y; Clem A; Ellis SR; Clark J; Clem B; Chesney J; Telang S
    Cancer Metab; 2014 Jan; 2(1):2. PubMed ID: 24451478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis.
    Kashyap A; Umar SM; Dev J R A; Mathur SR; Gogia A; Batra A; Deo SVS; Prasad CP
    J Cell Biochem; 2023 Sep; 124(9):1259-1272. PubMed ID: 37450687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation.
    Telang S; Clem BF; Klarer AC; Clem AL; Trent JO; Bucala R; Chesney J
    J Transl Med; 2012 May; 10():95. PubMed ID: 22591674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of PFKFB3 Hampers the Progression of Atherosclerosis and Promotes Plaque Stability.
    Poels K; Schnitzler JG; Waissi F; Levels JHM; Stroes ESG; Daemen MJAP; Lutgens E; Pennekamp AM; De Kleijn DPV; Seijkens TTP; Kroon J
    Front Cell Dev Biol; 2020; 8():581641. PubMed ID: 33282864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein kinase D3 promotes gastric cancer development through p65/6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 activation of glycolysis.
    Zhang J; Zhang Y; Wang J; Zhang S; Zhao Y; Ren H; Chu Y; Feng L; Wang C
    Exp Cell Res; 2019 Jul; 380(2):188-197. PubMed ID: 31026442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.